Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003256 |
---|---|
Receipt number | R000003891 |
Scientific Title | Carvedilol Post-Intervention long-Term Administration in Large-scale Randomized Controlled Trial |
Date of disclosure of the study information | 2010/03/31 |
Last modified on | 2021/02/19 18:32:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/02/25 08:38:29 | ||
2 | Update | 2010/02/25 08:45:08 | Narrative objectives1 |
|
3 | Update | 2010/08/13 09:11:19 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
4 | Update | 2010/08/25 09:10:40 | Recruitment status |
|
5 | Update | 2010/10/05 09:50:50 | Date of protocol fixation |
|
6 | Update | 2013/08/27 18:46:37 | Email Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2013/08/27 18:47:48 | Target sample size |
|
8 | Update | 2013/08/27 18:53:01 | Key inclusion criteria Key exclusion criteria |
|
9 | Update | 2013/08/27 18:57:38 | UMIN ID1 |
|
10 | Update | 2013/08/27 19:52:12 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
11 | Update | 2013/08/27 19:54:54 | Interventions/Control_2 Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
12 | Update | 2013/08/27 19:55:20 | Key secondary outcomes Key secondary outcomes |
|
13 | Update | 2013/08/27 20:00:44 | Condition |
|
14 | Update | 2017/02/17 17:24:56 | Randomization unit |
|
15 | Update | 2017/02/17 17:29:48 | Name of primary person or sponsor Organization Organization Organization Category of Funding Organization |
|
16 | Update | 2021/02/19 17:41:47 | Recruitment status Date of IRB Last follow-up date Other related information |
|
17 | Update | 2021/02/19 18:18:55 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
18 | Update | 2021/02/19 18:32:18 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of person sending information Name of person sending information Institute Department Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
19 | Update | 2021/02/19 18:32:52 | Last follow-up date |